Royce & Associates LP Zynex Inc Transaction History

Royce & Associates LP

$10.5 Billion
Q3 2024

A detailed history of Royce & Associates LP transactions in Zynex Inc stock. As of the latest transaction made, Royce & Associates LP holds 257,291 shares of ZYXI stock, worth $2.09 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

257,291

Previous 235,510 9.25%

Holding current value

$2.09 Million

Previous $2.19 Million 4.33%

% of portfolio

0.02%

Previous 0.02%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	BUY	$7.19 - $10.31 $156,605 - $224,562	21,781 Added 9.25%	257,291 $2.1 Million
Q2 2024 Aug 13, 2024	BUY	$8.63 - $12.56 $517,800 - $753,600	60,000 Added 34.19%	235,510 $2.19 Million
Q1 2024 May 13, 2024	BUY	$9.86 - $13.74 $1.73 Million - $2.41 Million	175,510 New	175,510 $2.17 Million
Q3 2023 Nov 09, 2023	SELL	$6.95 - $9.89 $126,927 - $180,621	-18,263 Reduced 27.86%	47,295 $378,000
Q2 2023 Aug 07, 2023	SELL	$8.59 - $14.56 $48,301 - $81,870	-5,623 Reduced 7.9%	65,558 $628,000
Q1 2023 May 04, 2023	SELL	$9.53 - $16.8 $76,516 - $134,887	-8,029 Reduced 10.14%	71,181 $854,000
Q4 2022 May 23, 2023	BUY	$8.71 - $14.28 $69,932 - $114,654	8,029 Added 11.28%	79,210 $1.1 Million
Q4 2022 Feb 13, 2023	BUY	$8.71 - $14.28 $116,261 - $190,609	13,348 Added 20.27%	79,210 $1.1 Million
Q3 2022 Nov 03, 2022	BUY	$7.19 - $9.91 $213,816 - $294,703	29,738 Added 82.32%	65,862 $597,000
Q2 2022 Aug 04, 2022	BUY	$5.78 - $8.87 $208,796 - $320,419	36,124 New	36,124 $288,000
Q1 2021 May 10, 2021	SELL	$12.28 - $19.74 $331,560 - $532,980	-27,000 Closed	0 $0
Q4 2020 Feb 08, 2021	SELL	$11.65 - $17.94 $582,500 - $897,000	-50,000 Reduced 64.94%	27,000 $363,000
Q3 2020 Nov 12, 2020	BUY	$12.98 - $25.98 $999,460 - $2 Million	77,000 New	77,000 $1.34 Million

Others Institutions Holding ZYXI

# of Institutions

103

Shares Held

8.4M

Call Options Held

200

Put Options Held

1.5K

View Full List

About ZYNEX INC

Ticker ZYXI
Exchange NASDAQ
Sector Healthcare
Industry Medical Distribution
Shares Outstandng 37,453,400
Market Cap $304M
Description
Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and n...

More about ZYXI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royce & Associates LP, based on Form 13F filings with the SEC.

News

Stay updated on Royce & Associates LP with notifications on news.

Account

Royce & Associates LP Zynex Inc Transaction History